ACRO Biomedical Co., Ltd. (TPEX:6748)

ACRO Biomedical Revenue

ACRO Biomedical had revenue of 27.82M TWD in the half year ending June 30, 2026, with 32.18% growth. This brings the company's revenue in the last twelve months to 52.76M, up 44.54% year-over-year. In the year 2025, ACRO Biomedical had annual revenue of 38.26M, down -13.51%.

• Revenue (ttm): 52.76M
• Revenue Growth: +44.54%
• P/S Ratio: 213.51
• Revenue / Employee: n/a
• Employees: 34
• Market Cap: 11.26B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	38.26M	-5.98M	-13.51%
Dec 31, 2024	44.23M	-6.83M	-13.38%
Dec 31, 2023	51.06M	23.43M	84.79%
Dec 31, 2022	27.63M	5.81M	26.59%
Dec 31, 2021	21.83M	3.80M	21.04%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 3, 2026

Data Sources Report a data error